Rocket Pharmaceuticals (RCKT) Goodwill & Intangibles (2018 - 2026)

Rocket Pharmaceuticals has disclosed Goodwill & Intangibles across 9 years of filings, most recently posting $64.3 million for Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $64.3 million, changed 0.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.3 million (changed 0.07% YoY), and the FY2025 annual result was $64.3 million, changed 0.07% from the prior year.
• Goodwill & Intangibles came in at $64.3 million for Q1 2026 at Rocket Pharmaceuticals, roughly flat from $64.3 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $64.9 million in Q4 2022 to a low of $30.8 million in Q1 2022.
• The 5-year median for Goodwill & Intangibles is $64.4 million (2023), against an average of $58.5 million.
• Across the five-year window, Goodwill & Intangibles jumped 110.69% in 2022 and declined 0.95% in 2024, its largest moves.
• Rocket Pharmaceuticals' Goodwill & Intangibles stood at $64.9 million in 2022, then dropped by 0.88% to $64.4 million in 2023, then changed by 0.0% to $64.4 million in 2024, then retreated by 0.07% to $64.3 million in 2025, then changed by 0.0% to $64.3 million in 2026.
• The last three Goodwill & Intangibles figures came in at $64.3 million (Q1 2026), $64.3 million (Q4 2025), and $64.3 million (Q3 2025), per Business Quant data.